News
- Home
- Investment Company News
- Want to live forever? FastForward Innovations invests in Juvenescence
Want to live forever? FastForward Innovations invests in Juvenescence – FastForward Innovations Limited has subscribed US$2 million for an approximate 0.8 per cent. equity interest in Juvenescence Limited, a BVI incorporated private company developing therapies to slow, halt and potentially reverse ageing. FFWD has subscribed as part of a US$50 million Series A fundraise that Juvenescence has now closed with a post-money valuation of US$250 million.
The Juvenescence founders and management team are focused on developing therapies for people to live longer, healthier lives. The Juvenescence founders include Jim Mellon, the non-executive chairman of FastForward, as well as Dr. Greg Bailey and Dr. Declan Doogan.
Since its incorporation in October 2016, Juvenescence has raised a total of US$63 million from a variety of international investors including family offices and leading institutions. The proceeds of the Juvenescence Series A funding will be used to advance key projects over the next 12 months with the board of Juvenescence reviewing options for a potential listing in 2019.
Juvenescence’s portfolio currently includes:
FFWD : Want to live forever? FastForward Innovations invests in Juvenescence
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated